We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening ...

Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectively Full Year 2025 target total global revenue of approximately $540 ...

NDAQ:TGTX) TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated ...

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated ...

EYLEA HD® and EYLEA® remained the U.S. anti-VEGF category leader in 2024; aggregate U.S. net product sales were $6 billion for full-year 2024, up 1% based on preliminary (unaudited) results EYLEA HD ...

HLA testing has been a staple in transplantation since the recognition that antibodies, directed against lymphocytes, were associated with allograft failure. This seminal finding led to the ...

Antibody fragment therapies are a type of biologic. They are typically fragments of monoclonal antibodies selected to bind to a particular protein (often a cell-surface protein), and produced ...

Doctors at AIIMS, Delhi are developing a low-cost, antibody-based adaptive cellular therapy targeting multiple myeloma, a type of blood cancer. This innovation aims to make advanced treatments like ...

PCPS plans to reopen the process in March. The Florida Legislature passed a law in 2023 requiring enhanced screening procedures for volunteers at public schools. The bill passed unanimously in ...

We used a systems-based approach that included deep and single-cell sequencing, bioinformatic and statistical analysis, and high-throughput antibody specificity screening to comprehensively ... the ...

TUESDAY, Dec. 17, 2024 (HealthDay News) -- A self-administered test can help empower women in identifying ... referred directly for further investigation with colposcopy [a medical procedure typically ...